Vetmab Biosciences is a veterinary biopharmaceutical company focused on developing best in class monoclonal antibody (“mAb”) therapeutics for dogs and cats. Our mission is to develop for pets the same caliber of innovative, safe and effective medicines to which we have access. We are developing a pipeline of novel mAbs across a number of high-value therapeutic areas. Vetmab Bio’s approach to mAb development is based on its proprietary antibody discovery platform, which enables the rapid identification and optimization of novel therapeutic antibodies with high affinity and specificity for their targets.
LifeSci
Vetmab Biosciences
OTHER COMPANIES
